Anand Mehra

CIK: 0001590102

Transaction Breakdown

Open Market Buys (P)1 (5.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (11.1%)

Derivative conversions

Awards (A)5 (27.8%)

Compensation grants

Other (G, F, J, C, D, …)10 (55.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ACRS

Aclaris Therapeutics, Inc.

Director

MRUS

Merus N.V.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

ACRS
Aclaris Therapeutics, Inc.
Jun 5, 2026
Exercise(M)
Direct
11.6K shares-
ACRS
Aclaris Therapeutics, Inc.
Jun 4, 2026
Award(A)
Restricted Stock Units
Direct
11K shares-
ACRS
Aclaris Therapeutics, Inc.
Jun 4, 2026
Award(A)
Stock Option (Right to Buy)
Direct
42.4K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
14.4K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
16.6K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
6.1K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
8.6K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
5.7K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
5K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
8.5K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
17K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
13.2K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
8.8K shares-
ACRS
Aclaris Therapeutics, Inc.
Jun 6, 2025
Exercise(M)
Direct
4.8K shares-
ACRS
Aclaris Therapeutics, Inc.
Jun 5, 2025
Award(A)
Stock Option (Right to Buy)
Direct
42.4K shares-
ACRS
Aclaris Therapeutics, Inc.
Jun 5, 2025
Award(A)
Restricted Stock Units
Direct
11.6K shares-
MRUS
Merus N.V.
May 22, 2025
Award(A)
Share Option (right to buy)
Direct
13.2K shares-
ACRS
Aclaris Therapeutics, Inc.
Nov 19, 2024
Purchase(P)
Direct
666.7K shares at avg. $2.25$1.5M

		Type	Shares	Price		Ownership
Jun 5, 2026	ACRS Aclaris Therapeutics, Inc.	Exercise(M)	11,580	-	$0	Direct
Jun 4, 2026	ACRS Aclaris Therapeutics, Inc.	Award(A) Restricted Stock Units	10,987	-	-	Direct
Jun 4, 2026	ACRS Aclaris Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	42,350	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	14,414	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	16,604	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	6,120	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	8,631	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	5,650	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	4,983	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	8,500	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	17,000	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	13,193	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	8,844	-	-	Direct
Jun 6, 2025	ACRS Aclaris Therapeutics, Inc.	Exercise(M)	4,793	-	-	Direct
Jun 5, 2025	ACRS Aclaris Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	42,350	-	-	Direct
Jun 5, 2025	ACRS Aclaris Therapeutics, Inc.	Award(A) Restricted Stock Units	11,580	-	-	Direct
May 22, 2025	MRUS Merus N.V.	Award(A) Share Option (right to buy)	13,193	-	-	Direct
Nov 19, 2024	ACRS Aclaris Therapeutics, Inc.	Purchase(P)	666,666	$2.25	$1,499,999	Direct

1-18 of 18 transactions

About Mehra Anand

Mehra Anand (SEC CIK 0001590102) files insider reports with the SEC as Director of Aclaris Therapeutics, Inc. (ACRS) and Director of Merus N.V. (MRUS).

Signal8 holds 5 ownership filings by Mehra Anand, all Form 4s, filed between Nov 20, 2024 and Jun 8, 2026. Those filings report 18 transactions, from Nov 19, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mehra Anand's filings is in WAYNE, PA.

Recent filings by Mehra Anand

Jun 5, 2026: Option exercise of ACRS shares (Form 4, code M).
Jun 4, 2026: Grants or awards of ACRS derivative securities (2 lines, Form 4, code A).
Dec 12, 2025: Disposition to issuer transactions of MRUS derivative securities (10 lines, Form 4, code D).
Jun 6, 2025: Option exercise of ACRS shares (Form 4, code M).
Jun 5, 2025: Grants or awards of ACRS derivative securities (2 lines, Form 4, code A).

Other insiders filing for Aclaris Therapeutics, Inc. (ACRS)

Kolbeck Roland Wilhelm, Chief Scientific Officer
SCHIFF ANDREW N, Director
Molineaux Christopher P., Director
Humphries William D., Director
MILANO VINCENT, Director
GOWEN MAXINE, Director

How to read Form 4 transaction codes